EP3722274A1 — 2-perfluorobutyl pentane for ophthalmic administration
Assigned to Novaliq GmbH · Expires 2020-10-14 · 6y expired
What this patent protects
The present invention is directed to a liquid composition comprising semifluorinated compounds of the general formulawherein n is 3 and m is 2.The composition is suitable for use as medicament for topical administration to the eye. Also provided is a kit comprising the compositio…
USPTO Abstract
The present invention is directed to a liquid composition comprising semifluorinated compounds of the general formulawherein n is 3 and m is 2.The composition is suitable for use as medicament for topical administration to the eye. Also provided is a kit comprising the composition and a container comprising a dispensing means such as a dropper.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.